Page last updated: 2024-12-05

propargyl bromide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Propargyl bromide is a haloalkyne that serves as a versatile building block in organic synthesis. It is a colorless liquid with a pungent odor. Its synthesis typically involves the reaction of propargyl alcohol with phosphorus tribromide. Propargyl bromide is widely employed in various chemical transformations, including nucleophilic substitution, Sonogashira coupling, and addition reactions. It is particularly valuable for constructing carbon-carbon bonds and introducing alkyne functionalities into organic molecules. Its reactivity stems from the electrophilic nature of the bromine atom and the presence of the triple bond, which can undergo both nucleophilic and electrophilic attack. Researchers study propargyl bromide to develop new synthetic methodologies, investigate its potential applications in medicinal chemistry, and explore its use in materials science.'

propargyl bromide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7842
SCHEMBL ID847
MeSH IDM0429129

Synonyms (65)

Synonym
ai3-26597
hsdb 6324
einecs 203-447-1
un2345
epa pesticide chemical code 068701
1-brom-2-propin [czech]
gamma-bromoallylene
brn 0605309
caswell no. 705
nsc 8801
.gamma.-bromoallylene
propyne, 3-bromo-
1-bromo-2-propyne
propynyl bromide
nsc-8801
3-bromo-1-propyne
propargyl bromide
1-propyne, 3-bromo-
2-propynyl bromide
nsc8801
wln: e2uu1
106-96-7
3-bromopropyne
yorciivhubaybq-uhfffaoysa-
inchi=1/c3h3br/c1-2-3-4/h1h,3h2
3-bromoprop-1-yne
P0484
P1272
AKOS000121563
3-bromo-prop-1-yne
1-brom-2-propin
3-bromopropyne [un2345] [flammable liquid]
unii-f3h7zxk9zu
4-01-00-00964 (beilstein handbook reference)
f3h7zxk9zu ,
FT-0615128
un 2345
BP-21498
SCHEMBL847
propargyl bromide [hsdb]
propargyl bromide (80% wt.in toluene) contains 0.3% magnesium oxide as stabilizer
c3h3br
progargyl bromide
3-bromoprop-1-yn
propargyl bromine
1-bromoprop-2-yne
3-bromo-1-propine
prop-2-ynyl bromide
3-bromo propyne
3-bromopropine
3-bromo-propyne
3-bromopropyn
2-propyn-1-yl bromide
propargylbromide
AM85466
STR00180
DTXSID3042340
mfcd00000241
J-512129
F2190-0179
Q7250094
propargyl bromide (~80% in toluene, stablized with 0.3% magnesium oxide)
EN300-17603
80% propargyl bromide in toluene
propargyl bromide solution

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Treatment of propargyl bromides that have nucleophilic functional groups connected by two or three carbon atoms with catalytic [Pd(PPh(3))(4)] affords bis-cyclization products in good yields."( Synthesis of fused and linked bicyclic nitrogen heterocycles by palladium-catalyzed domino cyclization of propargyl bromides.
Fujii, N; Kosaka, S; Maeda, H; Ohno, H; Oishi, S; Okano, A; Tanaka, T; Tsukamoto, K, 2010
)
0.93
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (35.29)29.6817
2010's20 (58.82)24.3611
2020's2 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.49 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index79.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (51.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.78%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (97.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]